Negative Pressure Wound Therapy. Therapy Effects and the Impact on the Patient's Quality of Life

Sponsor
Karolinska Institutet (Other)
Overall Status
Terminated
CT.gov ID
NCT01191567
Collaborator
Stockholm South General Hospital (Other)
30
1
2
22
1.4

Study Details

Study Description

Brief Summary

Wounds have long been a source of suffering for unfortunate victims and in recent years new complementary methods have been developed in areas where traditional wound treatment has been insufficient. Treating wounds with negative pressure, Vacuum assisted closure® [VAC], is a relatively new method of treatment and knowledge about its effect on patients is limited.

Earlier studies haven't been able to answer the question about which groups of patients that are in most favour of the treatment and what impact the treatment has on the patient's quality of life.

It is important with further research since an effective and mild wound treatment can decrease suffering and increase quality of life for the patient. Wound treatment that does not lead to an achieved treatment goal can lead to a risk for the patient and should be avoided.

The project consists of 4 part studies: Study 1 and 2 are chart review studies of a consecutive series of patients treated with VAC at Södersjukhuset during a 3 year period. The patients are described on the basis of medical, surgical and demographical factors. Outcome is treatment results and risk factors for a treatment failure.

Study 3 and 4 are clinical randomised studies with the aim of studying whether treatment with VAC provides a faster and more effective healing of acute and postoperative wounds, and in what way the treatment affect the quality of life and pain of the patients, compared to conventional treatment.

Condition or Disease Intervention/Treatment Phase
  • Procedure: VAC treatment
  • Procedure: Conventional treatment
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Negative Pressure Wound Therapy. Therapy Effects and the Impact on the Patient's Quality of Life
Study Start Date :
Sep 1, 2010
Actual Primary Completion Date :
Jul 1, 2012
Actual Study Completion Date :
Jul 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conventional treatment

Procedure: Conventional treatment
wound treatment with conventional treatment according to the hospitals local routines

Experimental: VAC treatment

Procedure: VAC treatment
wound treatment with VAC-therapy

Outcome Measures

Primary Outcome Measures

  1. treatment results [2 weeks]

    successfully treated or non-successfully treated

  2. wound size [2 weeks]

    meassured with Visitrak

  3. Quality of life [2 weeks]

    meassured with EQ-5D form and a diary with content analysis

Secondary Outcome Measures

  1. Number of Participants with Adverse Events as a Measure of Safety and Tolerability [2 weeks]

  2. costs for treatment [2 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • acute wounds with substance defect after primary suture demanding further treatment or wounds not primary sutured

  • wounds with osteosynthesis, bone or tendon visual regardless wound size

  • postoperative infections with wound and substance defect demanding further treatment.

  • fasciotomy on extremity

Exclusion Criteria:
  • wound size < 2 cm and depth < 1 cm

  • pressure ulcers, open abdomen and chronic ulcers

  • patients with dementia or mental illness so severe that participation in the study is impossible

  • patients non in command of the swedish language

  • ongoing treatment with warfarin

Contacts and Locations

Locations

Site City State Country Postal Code
1 Södersjukhuset Stockholm Sweden 11883

Sponsors and Collaborators

  • Karolinska Institutet
  • Stockholm South General Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ann-Mari Wallin, RN, PhD, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT01191567
Other Study ID Numbers:
  • 2008/2023-31
First Posted:
Aug 31, 2010
Last Update Posted:
Nov 17, 2017
Last Verified:
Nov 1, 2017
Keywords provided by Ann-Mari Wallin, RN, PhD, Karolinska Institutet
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 17, 2017